Bedside Snapshot
- Indications
- Failure to maintain or protect the airway
- Failed oxygenation or ventilation despite NIV or HFNC
- Anticipated deterioration (transport, combative trauma)
- Contraindications / Abort
- Flaccid, apneic or in arrest: crash airway, no RSI drugs
- Predicted can't intubate, can't oxygenate: awake technique
- Succinylcholine: MH history, myopathy, hyperkalemia risk
- Abort if SpO₂ <90% or the attempt passes 30 s
- Critical Steps
- Resuscitate first: SBP, shock index, SpO₂, pH
- Preoxygenate: NIV preferred; apneic oxygenation at 15 L/min
- Induction and paralytic given together; BVM ready
- Video laryngoscope, ≤ 30 s per attempt, bougie early
- Confirm & Monitor
- Sustained waveform EtCO₂ over at least 5–6 breaths
- Sedation and analgesia started at once
- BP every 3–5 min; push-dose pressor drawn up
- Recheck tube depth and EtCO₂ after every move
Key Numbers
Use these numbers at the bedside. Each adult and pediatric value is per kilogram of the weight your protocol specifies; drug choice and doses vary by protocol and must follow local protocols and medical direction.
| Parameter | Value |
|---|---|
| Attempt duration | ≤ 30 s per laryngoscopy attempt; abort if SpO₂ <90% |
| Attempts | Commonly limited to 3 attempts per local protocol, then move to the next plan (Plan B SGA, Plan C facemask, Plan D front-of-neck access) |
| Apneic oxygenation | Nasal cannula 15 L/min (or HFNC) through every attempt |
| Induction: ketamine | Adult: 1–2 mg/kg IV/IO Peds: 1–2 mg/kg IV/IO |
| Induction: etomidate | Adult: 0.3 mg/kg IV, single dose only (reduced dose in shock, 0.2–0.25 mg/kg, is protocol or expert practice and not label-sourced) Peds: 0.3 mg/kg IV (label: age ≥10 yr); avoid in sepsis or septic shock (SSC Children 2026, conditional, low certainty) |
| Paralytic: rocuronium | Adult: 1–1.2 mg/kg IV (label RSI range 0.6–1.2 mg/kg) Peds: 1 mg/kg IV/IO (off-label; max 1.2 mg/kg). Differs from FDA label: the label does not recommend rocuronium for pediatric RSI (intubating dose 0.6 mg/kg) |
| Paralytic: succinylcholine | Adult: 1–1.5 mg/kg IV (label intubation dose 0.6 mg/kg) Peds: 2 mg/kg (infants, small children); 1 mg/kg (older children) |
| Rescue reversal | Sugammadex 16 mg/kg IV about 3 min after rocuronium 1.2 mg/kg (actual body weight; not studied in children) |
| Push-dose epinephrine | 10–20 mcg IV (1–2 mL of 10 mcg/mL) every 2–5 min to target; no evidence-based pediatric dose |
Overview & Principles
RSI pairs a fast-acting induction agent with a paralytic, and both go in together. That puts the patient under and relaxes the muscles for tracheal intubation. The goal is good intubating conditions in the shortest time, because the airway stays unprotected the entire time.
How It Works
- Induction agent: puts the patient under. Your choice depends on hemodynamics (see Medications & Settings).
- Paralytic: relaxes the muscles so the laryngoscopist can see the cords. It also stops spontaneous breathing.
- Oxygen throughout: preoxygenation, apneic oxygenation and gentle bag-mask ventilation (BVM) keep desaturation in check.
- Confirmation: sustained waveform capnography (EtCO₂) is how you prove tube position.
- Sedation and analgesia: must start at once. A paralyzed patient cannot show you they are aware.
Where It Fits
RSI lives inside the Difficult Airway Society (DAS) linear algorithm. Plan A is tracheal intubation. Plan B is a second-generation supraglottic airway (SGA). Plan C is facemask ventilation, and Plan D is an emergency front-of-neck airway. Non-drug options can be the better choice when the patient is safer without paralysis: noninvasive ventilation (NIV), high-flow nasal cannula (HFNC), awake intubation, delayed sequence intubation (DSI) and rapid sequence airway (RSA).
Indications & Contraindications
Indications
- Failure to maintain or protect the airway: declining mental status, severe intoxication, head injury with loss of protective reflexes.
- Failure of oxygenation or ventilation despite NIV or HFNC.
- Anticipated deterioration: transport of a patient who will worsen, combative trauma, inhalation injury, or airway burns.
RSI drugs are not needed when the patient is deeply comatose, flaccid and apneic, or in cardiac arrest. That is a crash airway, and it gets no drugs. Depressed consciousness with tone or gag reflexes still present? That patient is a candidate for RSI.
Absolute Contraindications
None, when intubation is truly indicated. Drug-specific contraindications apply, too (see succinylcholine under Medications & Settings).
Relative Contraindications & Cautions
- Profound shock: SBP <90 mmHg or shock index >0.9. Start a vasopressor before induction and reduce induction doses.
- Severe acidosis (pH <7.2): the patient depends on high minute ventilation. Apnea worsens acidosis quickly.
- Severe hypoxemia (for example ARDS or pneumonia), right heart failure or massive pulmonary embolism.
- Predicted "can't intubate, can't oxygenate": consider awake intubation before paralysis.
- Succinylcholine-specific risks: malignant hyperthermia (MH) susceptibility, skeletal muscle myopathy, hyperkalemia, and burns, crush, denervation or upper motor neuron injury after the acute phase.
Consider an Alternative
Alternatives to RSI: NIV or HFNC for oxygenation. Awake intubation with topical anesthesia for a predicted difficult airway. DSI for an agitated hypoxemic patient who cannot be preoxygenated. An SGA when intubation is not needed to protect the airway.
Abort / Stop Criteria
Abort the attempt and ventilate with BVM. Do it if SpO₂ falls below 90% or the attempt runs past about 30 seconds.
Scope & Team Roles
| Provider Level | Typical Role | Notes |
|---|---|---|
| EMT | Assists | Suction, positioning and bag-mask ventilation; no RSI drugs |
| AEMT | Assists | Suction, supraglottic airway if protocol allows; RSI drugs not in scope |
| Paramedic | Performs (protocol/credentialing required) | Not in national model: state/agency credentialing and medical direction required |
| RN (ED/ICU) | Monitors & maintains | Medication clinician and post-intubation sedation under local protocol |
| Critical Care Transport (CFRN / CTRN / FP-C / CCP-C) | Performs (protocol/credentialing required) | Not in national model: medical direction and credentialing required |
| Physician / APP | Performs | Operator for difficult or failed attempts |
Team Roles During the Procedure
- Operator: performs laryngoscopy and calls the plan.
- Airway/oxygen manager: preoxygenation, BVM and apneic oxygenation.
- Medication clinician: draws up and gives drugs, reads each label aloud.
- Monitor and recorder: watches SpO₂, ECG, BP and EtCO₂, and times the attempt.
Pre-Procedure Assessment
Anatomic Difficulty
| Component | Assess | Concerning Findings |
|---|---|---|
| LEMON: Look externally | Face, jaw, neck and body habitus | Facial trauma, large tongue, obesity, beard |
| LEMON: Evaluate 3-3-2 | Mouth opening, hyoid-to-chin and thyroid-to-hyoid distance | Less than 3 fingers mouth opening; short distances |
| LEMON: Mallampati | Tongue size relative to pharynx | Higher class (tongue fills view) |
| LEMON: Obstruction / Obesity | Airway obstruction, neck and body size | Stridor, mass, obesity |
| LEMON: Neck mobility | Range of motion; cervical spine status | Fixed flexion, cervical spine injury |
| HEAVEN: Hypoxemia, Extremes of size, Anatomic challenges, Vomit/blood/fluid, Exsanguination/anemia, Neck mobility | Physiology and anatomy that predict failure | Any item predicts a difficult or unsafe attempt |
Predict rescue ventilation and supraglottic airway difficulty with MOANS and RODS. Predict cricothyrotomy difficulty with SMART. Do both before the first attempt.
Physiologic Risk
Physiology causes more peri-intubation deaths than anatomy does. Each trigger below is a reason to optimize first:
- SBP <90 mmHg or shock index >0.9.
- SpO₂ <93% on the best oxygen available.
- pH <7.2 or a high work of breathing.
- Right heart failure or massive pulmonary embolism; severe ARDS with high PEEP requirement.
Site / Device Check
Confirm suction is on and within reach, BVM with PEEP valve is connected, the second-generation SGA and surgical airway kit are present, waveform EtCO₂ is connected, and the push-dose vasopressor is labeled and ready.
Equipment & Preparation
| Item | Size / Spec | Notes |
|---|---|---|
| Video laryngoscope | Adult and pediatric blades per protocol | First-line where available; direct laryngoscope as backup |
| Bougie | Standard adult and pediatric | Ready before induction; use it when the view is poor |
| Cuffed endotracheal tube | Per protocol and body size; pediatric by length-based tape or Broselow | Check cuff; stylet ready |
| Second-generation SGA | Adult and pediatric sizes | Plan B if intubation fails |
| Surgical airway kit | Scalpel, bougie, cuffed tube | Plan D; see the cricothyrotomy page |
| Suction | Rigid (Yankauer) and tubing | On and within reach before induction |
| Oxygen and BVM | Non-rebreather, nasal cannula, BVM with PEEP valve; NIV or HFNC if available | Preoxygenation and rescue ventilation |
| Monitoring | ECG, SpO₂, waveform EtCO₂, BP | BP every 3–5 min after induction |
| Vasopressors | Push-dose epinephrine and phenylephrine; infusion ready | Labeled, pharmacy-prepared where available |
Pre-Procedure Checklist
- Plan A, B, C and D stated aloud by the operator
- Roles assigned; medication clinician reads each drug and dose aloud
- Suction on; BVM and PEEP valve connected; oxygen at full flow
- Video laryngoscope and direct laryngoscope checked; bougie open
- Waveform EtCO₂ connected; monitors on and alarms set
- Second-generation SGA and surgical airway kit at the bedside
- Induction and paralytic drawn up and labeled
- Push-dose vasopressor labeled and ready; infusion available
- Sedation and analgesia drawn up for immediately after intubation
- Pediatric sizes and doses checked against weight or length tape
Patient Positioning & Preparation
Ramp the patient so the ear aligns with the sternal notch. Preoxygenate in this position, and keep head and neck in line when cervical spine injury is possible.
Medications & Settings
These are typical adult and pediatric references. Before you use one, check it against local protocol and current drug labeling.
| Drug | Adult Dose | Pediatric Dose | Onset / Duration | Notes |
|---|---|---|---|---|
| Ketamine | 1–2 mg/kg IV/IO over 30–60 s (single induction dose; no fixed max) | 1–2 mg/kg IV/IO | IV 30 s / 5–10 min | High-alert Preserves BP in most patients. In the 2026 RSI trial it caused more peri-intubation cardiovascular collapse than etomidate (22.1% vs 17.0%). Reduced dose in shock per protocol. |
| Etomidate | 0.3 mg/kg IV over 30–60 s (label range 0.2–0.6 mg/kg); reduced dose in shock (0.2–0.25 mg/kg) per protocol or expert practice, not label-sourced | 0.3 mg/kg IV (age ≥10 yr); under 10 yr not in label, specialist use. Avoid in children with sepsis or septic shock (SSC Children 2026, conditional, low certainty) | IV <1 min / 3–5 min | High-alert Preferred when hemodynamics are fragile. Transient adrenal suppression (label warning). Adult septic shock: acceptable as a single induction dose; do not use for infusions or repeat dosing. In the 2026 RSI trial, 28-day in-hospital death was 29.1% with etomidate vs 28.1% with ketamine (adjusted difference −0.8 points favoring ketamine; not significant). |
| Propofol | 1–2.5 mg/kg IV, titrated (lower end if older or ASA III–IV; single induction dose) | 2.5–3.5 mg/kg IV (age 3–16 yr) | IV 30–40 s / about 6 min | High-alert Not for shock or MAP <65 mmHg. Vasodilation and apnea; use only if BP allows. |
| Rocuronium | 1–1.2 mg/kg IV/IO (label RSI range 0.6–1.2 mg/kg; max 1.2 mg/kg) | 1 mg/kg IV/IO (off-label; max 1.2 mg/kg). Differs from FDA label: the label does not recommend rocuronium for pediatric RSI; labeled intubating dose 0.6 mg/kg | IV 1 min / 60–70+ min | High-alert Alternative when succinylcholine is contraindicated. At 1.2 mg/kg clinical relaxation lasted 67 min (range 38–160). Reversal: sugammadex (below). |
| Succinylcholine | 1–1.5 mg/kg IV, actual body weight (label intubation dose 0.6 mg/kg; no labeled IV max) | 2 mg/kg IV (infants, small children); 1 mg/kg IV (older children, adolescents) | IV <1 min / 4–6 min | High-alert Contraindications in the section below. Bradycardia, especially in children and after a second dose; atropine pretreatment may reduce it. |
| Sugammadex (reversal) | 16 mg/kg IV about 3 min after rocuronium 1.2 mg/kg (actual body weight); 2 mg/kg for routine reversal | Immediate 16 mg/kg not studied in children | IV 2–3 min to reversal | Not for succinylcholine. Not recommended if creatinine clearance is <30 mL/min or on dialysis. |
| Fentanyl (pretreatment) | 1 mcg/kg IV (usual 25–100 mcg; max initial 100 mcg), if the protocol uses pretreatment | 1 mcg/kg IV/IO (max initial 100 mcg) | IV 1–2 min / 30–60 min | High-alert Opioid. Blunts the sympathetic response in hypertensive or tachycardic patients. Chest wall rigidity after a fast bolus. |
| Epinephrine (push-dose) | 10–20 mcg IV (1–2 mL of 10 mcg/mL) every 2–5 min to target; off-label | No evidence-based dose; specialist or protocol use only | IV rapid onset; short duration (minutes). Repeat to effect per protocol | High-alert Made from 0.1 mg/mL: 1 mL in 9 mL NS. Never push 1 mg/mL undiluted. Prefilled product preferred. |
| Phenylephrine (push-dose) | 50–100 mcg IV bolus every 1–2 min as needed (max 200 mcg per bolus) | Specialist use only; no pediatric dose is given on this page. Use only under specialist guidance | IV rapid / up to 20 min | High-alert Use the 100 mcg/mL bolus product. Never push the 10 mg/mL concentrate undiluted. Reflex bradycardia. |
Post-Intubation Sedation & Analgesia
- Analgesia first: fentanyl infusion 0.7–10 mcg/kg/hr (ICU range; titrate to the protocol target).
- Propofol infusion: start 5 mcg/kg/min; usual 5–50 mcg/kg/min if BP allows. When you need deeper sedation, or faster titration, propofol is the house choice.
- Dexmedetomidine: 1 mcg/kg IV over 10 min, then 0.2–0.7 mcg/kg/hr (ICU range), for light sedation. (PADIS 2025 gives a conditional recommendation for dexmedetomidine over propofol for sedation of ventilated adults.) The label flags hypotension and bradycardia. The loading dose may not be required when you convert from other sedatives. If the patient is hemodynamically unstable, omit or reduce the loading dose. Do not use dexmedetomidine as first-line sedation right after RSI.
- Hypotension: cut back the sedative, treat the BP, and reassess. Pick a sedative the patient's hemodynamics can tolerate, per protocol.
Paralytic Dosing Notes
- Succinylcholine: label intubation dose is 0.6 mg/kg (range 0.3–1.1 mg/kg); RSI practice commonly uses 1–1.5 mg/kg. Confirm the local dose.
- Rocuronium: label gives 0.6–1.2 mg/kg for RSI; 1.2 mg/kg gave about 67 min of clinical relaxation (range 38–160 min), so plan sedation and the next airway step accordingly.
| Setting | Adult | Pediatric | Notes |
|---|---|---|---|
| Weight basis | Dosing weight per protocol (actual body weight for succinylcholine and sugammadex) | Actual body weight; length-based tape where weight is unknown | State the basis on the drug label used |
| Ventilation after intubation | Start per the intubation page | Per pediatric protocol | Titrate SpO₂ and EtCO₂ to target |
Step-by-Step Procedure
Phase 1: Prepare
- Resuscitate and optimize: assess SBP, shock index, SpO₂ and pH. Correct real hypovolemia or bleeding with blood for hemorrhage. A routine prophylactic fluid bolus does not prevent peri-intubation collapse (PREPARE II). Start a vasopressor before induction if the patient is hypotensive.
- Brief the team: name roles, the first attempt and Plans A to D, and the drug doses aloud.
- Check equipment: suction on, BVM with PEEP valve, video laryngoscope, bougie, SGA, surgical airway kit and monitors. Label every syringe and the push-dose vasopressor.
- Position: ramp the patient so the ear aligns with the sternal notch.
- Preoxygenate: use NIV for hypoxemic patients (PREOXI). Use a non-rebreather with nasal cannula at 15 L/min when NIV is not available. Continue about 3–5 minutes, or until EtO₂ is maximized if monitored.
Phase 2: Perform
- Give pretreatment if the protocol uses it: fentanyl 1 mcg/kg IV for a hypertensive or tachycardic patient. Timing per protocol.
- Give the induction agent at the dose in the table, over 30–60 seconds.
- Give the paralytic immediately after the induction agent (near-simultaneous), then flush.
- Apply apneic oxygenation: nasal cannula at 15 L/min or HFNC through every attempt.
- Ventilate if the patient desaturates: gentle BVM with PEEP valve between induction and laryngoscopy reduced severe hypoxemia (PREVENT) without increasing aspiration.
- Wait for relaxation, about 1 minute for rocuronium and succinylcholine in label data. Do not laryngoscope before the jaw is relaxed.
- Laryngoscopy: video laryngoscope first-line. Limit the attempt to about 30 seconds and use the bougie early if the view is poor.
Phase 3: Confirm & Secure
- Pass the tube and inflate the cuff at the depth that the protocol uses. Stop the attempt if SpO₂ falls below 90%.
- Confirm placement: sustained waveform EtCO₂ over at least 5–6 breaths (see Confirmation & Monitoring).
- Secure the tube with a commercial holder or well-applied tape and document depth.
- Start ventilation with lung-protective settings (see the intubation page).
- Start sedation and analgesia immediately, analgesia first, while the paralytic is still active.
- Reassess hemodynamics every 3–5 minutes; positive pressure ventilation and induction drugs can drop BP. Use push-dose vasopressor or infusion as needed.
Alternative Technique: Delayed Sequence Intubation (DSI)
Think of DSI for the combative, hypoxemic patient who cannot be preoxygenated. Give a dissociative dose of ketamine per protocol while the patient keeps breathing. Then preoxygenate with a high-flow nonrebreather or NIV. Move on to standard RSI once oxygenation is adequate. The dissociative dose is set by protocol. It goes in slowly, with extra aliquots to effect.
Alternative Technique: Rapid Sequence Airway (RSA)
Place a supraglottic airway after induction and paralysis. It bridges the patient to oxygenation and ventilation. Then reattempt intubation once the patient is optimized. Use it when laryngoscopy is failing, or when no intubation attempt is safe.
Confirmation & Monitoring
Primary Confirmation
A sustained waveform EtCO₂ across at least 5–6 breaths is your proof of tracheal placement. Without one, treat the tube as esophageal until shown otherwise. Pull it, re-oxygenate, then either re-attempt or place an SGA.
Secondary Confirmation
- Bilateral chest rise with each BVM breath.
- Equal breath sounds in both axillae (listen high to avoid transmitted sounds).
- No epigastric sounds during ventilation.
- SpO₂ rises after intubation rather than falling.
- Ultrasound or chest radiograph to check depth when the tube position is uncertain.
| Finding | Success | Failure / Malposition |
|---|---|---|
| Waveform EtCO₂ | Sustained plateau waveform over 5–6 breaths | Small irregular trace, or no trace |
| Chest rise | Symmetric with ventilation | One side only, or none |
| Breath sounds | Equal in both axillae | Absent on one side, or epigastric sounds |
| SpO₂ trend | Rising or stable | Falling despite ventilation |
Ongoing Monitoring
- Continuous waveform EtCO₂ for the whole procedure and transport.
- SpO₂ and BP every 3–5 minutes after induction.
- Recheck tube depth and capnography after every move and handoff.
- Check the train-of-four or clinical twitch before any repeat paralytic dose.
Troubleshooting
| Problem | Likely Cause | Fix |
|---|---|---|
| SpO₂ falls during the attempt | Long attempt; poor preoxygenation; secretions | Abort, ventilate with BVM and PEEP valve, re-oxygenate, reassess |
| Hypotension after induction | Induction drug, positive pressure, lost catecholamine drive | Push-dose vasopressor or infusion; fluid if hypovolemic; reduce further induction dose |
| Poor laryngoscopic view | Positioning, secretions, anatomy | Re-ramp, external laryngeal manipulation, bougie, switch device |
| No waveform EtCO₂ | Esophageal placement or tube dislodgement | Remove tube, re-oxygenate, re-attempt or place SGA |
| Bradycardia after succinylcholine | Vagal effect; second dose; children | Adult: atropine 1 mg IV, repeat every 3–5 min to a maximum total of 3 mg (2025 AHA ACLS bradycardia algorithm). Pediatric: 0.02 mg/kg IV/IO, may repeat once; minimum 0.1 mg, maximum single dose 0.5 mg (2025 AHA PALS bradycardia algorithm). Prepare pacing if it persists |
| Movement before paralysis is complete | Paralytic not yet effective or a low dose | Wait; do not laryngoscopize with movement; give sedation per protocol |
| Tube passes but ventilation is difficult | Mainstem intubation, obstruction, bronchospasm | Check depth, suction, consider bronchospasm treatment |
If It Still Fails
- Stop, oxygenate: BVM with PEEP valve, SpO₂ target maintained.
- Plan B: second-generation SGA ventilation.
- Plan C: two-person facemask ventilation.
- Cannot intubate, cannot oxygenate (CICO): declare it, ensure full paralysis, perform a scalpel-bougie-tube cricothyrotomy (see the cricothyrotomy page).
Complications
| Complication | Recognition | Prevention | Management |
|---|---|---|---|
| Immediate: peri-intubation cardiovascular collapse | SBP <65 mmHg, new or increased vasopressor need, or cardiac arrest (trial definitions) | Vasopressor before induction; reduced induction dose; no routine fluid bolus | Push-dose vasopressor, vasopressor infusion, gentle ventilation; resuscitate per protocol |
| Immediate: hypoxemia during intubation | SpO₂ <85% during the intubation window (PREOXI definition; PREVENT used SpO₂ <80% for severe hypoxemia) | NIV preoxygenation; apneic oxygenation; attempt limit | Abort, BVM with PEEP valve, re-oxygenate |
| Immediate: aspiration | Vomit or fluid in the airway; suction return | Ramped position; suction ready; gentle BVM only as needed | Suction, lateral positioning, continued ventilation with the tube in place |
| Immediate: esophageal intubation | No waveform EtCO₂; epigastric sounds | Confirm every tube with EtCO₂ | Remove the tube, re-oxygenate, reattempt or SGA |
| Delayed: awareness under paralysis | Tachycardia, hypertension, tearing, movement (may be absent) | Sedation and analgesia started immediately | Deepen sedation and analgesia per protocol; check the ventilator |
| Delayed: post-intubation hypotension | BP falls after tube placement | Pressor ready; reassess every 3–5 min | Push-dose vasopressor, fluids if volume-responsive, infusion |
| Rare: malignant hyperthermia | Rising EtCO₂, rigidity, tachycardia, fever | Avoid succinylcholine in MH-susceptible patients | Stop trigger drugs; treat per protocol with dantrolene (see the dantrolene page) |
| Rare: laryngospasm after ketamine | Stridor, falling EtCO₂ | Adequate dose; manage secretions | Positive-pressure ventilation; treat per the airway protocol |
Hyperkalemic cardiac arrest after succinylcholine
- Recognize: peaked T waves, widening QRS or arrest within minutes of the dose.
- Treat: resuscitate per ACLS (adult) or PALS (child). Adult: calcium chloride 1 g (10 mL of 10%) IV/IO push; sodium bicarbonate 50 mEq IV/IO, repeat by blood gas; insulin 10 units IV with dextrose 50 g (D50) over 15–30 min. Child: insulin 0.1 units/kg IV over 15–30 min (max 10 units) with D10W 5 mL/kg (0.5 g/kg) IV bolus. AHA 2025 Part 10 gives no pediatric per-kg dose for calcium or bicarbonate, so this page gives none for children. The 2025 AHA Guidelines for CPR and ECC, Part 10, rate IV calcium, sodium bicarbonate and insulin-glucose COR 2b (effectiveness not well established) and inhaled beta-2 agonists COR 3: No Benefit in adults and children, so do not give albuterol in arrest. Differs from UKKA 2026 and ERC: those give 25 g dextrose.
- Prevent: screen for hyperkalemia, myopathy and burn or crush injury before any succinylcholine dose.
Special Populations
Pediatrics
| Drug | Pediatric Dose | Notes |
|---|---|---|
| Ketamine | 1–2 mg/kg IV/IO | Preserves BP in most; reduce dose in shock |
| Etomidate | 0.3 mg/kg IV (age ≥10 yr) | Under 10 yr: not in label; specialist use. Avoid in children with sepsis or septic shock (SSC Children 2026, conditional, low certainty) |
| Rocuronium | 1 mg/kg IV/IO (off-label; max 1.2 mg/kg; Bisesi 2024) | Differs from FDA label: the label does not recommend rocuronium for pediatric RSI (intubating dose 0.6 mg/kg); long paralysis |
| Succinylcholine | 2 mg/kg (infants, small children); 1 mg/kg (older children) | Hyperkalemic arrest risk in undiagnosed myopathy (boxed warning) |
| Atropine | 0.02 mg/kg IV/IO for symptomatic bradycardia; may repeat once; minimum 0.1 mg, maximum single dose 0.5 mg (2025 AHA PALS bradycardia algorithm) | Keep ready before succinylcholine, especially second doses |
- Desaturation: Children desaturate faster. Preoxygenate longer if the child can tolerate it, and use apneic oxygenation.
- Tube size: Use length-based tape or the Broselow tape per local protocol. Check cuff pressure.
- Succinylcholine: The boxed warning covers hyperkalemic rhabdomyolysis and cardiac arrest. It applies to apparently healthy children with undiagnosed myopathy (for example Duchenne).
Older Adults
- Some older patients are more sensitive to rocuronium (label). Use lower doses of propofol, and titrate.
- Older patients have less oxygen reserve. Preoxygenate fully, and do not rush the attempt.
Pregnancy
- Pregnant patients desaturate fast. Start nasal oxygenation and mask ventilation right after induction. Keep them going through the attempt.
- Use lateral uterine displacement as indicated. Consider a 20–30° head-up position before the first attempt (OAA/DAS 2015).
- Limit intubation attempts to two. Then move early to a second-generation supraglottic airway, per the OAA/DAS obstetric guideline.
- If intubation is difficult, consider releasing cricoid pressure early.
- If the patient can be neither intubated nor oxygenated, follow the CICO pathway. Timely perimortem cesarean delivery is part of the obstetric algorithm.
Obesity
- Obese patients desaturate faster. Preoxygenate fully, ramp the patient, and use apneic oxygenation.
- Dose the paralytic on the weight basis the protocol specifies. Succinylcholine goes on actual body weight (see Dosing basis).
Traumatic Brain Injury
- Hypotension and hypoxia make secondary brain injury worse. Avoid both before, during and after RSI. Treat hypotension early, against the local TBI blood-pressure target.
- When a cervical spine injury is possible, keep in-line stabilization (see Positioning).
Renal Failure or Dialysis
- Sugammadex is not recommended if creatinine clearance is under 30 mL/min or on dialysis (label). Use the alternative reversal per protocol.
Physiologically Difficult Airway
Pre-Procedure Assessment and Indications already cover shock, severe hypoxemia, acidosis and right heart failure. Use the physiologic plan before any paralytic.
Post-Procedure Care & Transport
Immediate Aftercare
- Recheck tube depth, EtCO₂ and breath sounds after every move.
- Start sedation and analgesia immediately, analgesia first.
- Set the ventilator; titrate SpO₂ to the target in the intubation page.
Ongoing Maintenance
Check cuff pressure within the range the protocol sets (commonly 20–30 cm H₂O). Keep the tube secure and document the depth at the lip or teeth.
Transport Considerations
- Secure the tube and reconfirm EtCO₂ after every move, loading or handoff.
- Expect cuff pressure changes with altitude; check during flights.
- Vibration and noise make auscultation unreliable; rely on EtCO₂ and waveform monitoring.
- Paralysis from rocuronium can last an hour or more; keep sedation running during transport.
| Setting | Adult Target | Notes |
|---|---|---|
| Tidal volume | Per the intubation page (ideal body weight) | 6 mL/kg ideal body weight for ARDS |
| PEEP | Start 5 cm H₂O | Increase cautiously in hypoxemia |
| FiO₂ | Titrate to SpO₂ target | SpO₂ 92–96% typical (88–92% in COPD) |
Document & Hand Off
- Time of induction and of each drug, with dose and weight used
- Device, tube size, depth at lip or teeth, and blade
- Number of attempts and the first-pass result
- Confirmation method and EtCO₂ value
- Ventilator settings, sedation and analgesia started
- Complications and the patient's response
Clinical Pearls & Pitfalls
Pearls
- Resuscitate before you intubate: Optimize BP, oxygenation and acid-base status before you push any drugs.
- Oxygen all the way: NIV for hypoxemic patients. Apneic oxygenation runs through every attempt.
- Bag between induction and laryngoscopy when the patient is desaturating.
- Plan the rescue first: Have the SGA and surgical airway ready before the paralytic goes in.
- Video laryngoscope first-line where available. Switch devices instead of repeating a failed attempt.
Common Pitfalls
- Propofol in shock: Use a hemodynamically stable agent at a reduced dose. Resuscitate first.
- Routine fluid bolus as prophylaxis: It does not prevent collapse. Treat real hypovolemia.
- Forgetting post-intubation sedation: The paralyzed patient cannot show you they are aware.
- Repeating the same failed attempt: The fix is a change of device, position or plan.
- No waveform, assumed placement: Remove the tube and re-attempt. Keep going until EtCO₂ confirms it.
Education & Skill Maintenance
Skill Maintenance
- Run RSI simulation at least every few months with the full team, including the medication clinician.
- Practice the push-dose vasopressor preparation and label check until it is routine.
- Rehearse the failed-airway pathway, including the CICO trigger and the scalpel-bougie-tube sequence.
- Debrief every intubation: first-pass success, peak desaturation and time to confirmation.
References
- Ahmad I, El-Boghdadly K, Iliff H, et al. Difficult Airway Society 2025 guidelines for management of unanticipated difficult tracheal intubation in adults. Br J Anaesth. 2026;136(1):283-307. doi:10.1016/j.bja.2025.10.006. https://doi.org/10.1016/j.bja.2025.10.006
- Casey JD, Seitz KP, Driver BE, et al. Ketamine or Etomidate for Tracheal Intubation of Critically Ill Adults (RSI trial). N Engl J Med. 2026;394(16):1608-1620 (online Dec 2025). doi:10.1056/NEJMoa2511420. https://doi.org/10.1056/NEJMoa2511420
- Gibbs KW, et al. Noninvasive Ventilation for Preoxygenation during Emergency Intubation (PREOXI). N Engl J Med. 2024;390(23):2165-2177. doi:10.1056/NEJMoa2313680. https://doi.org/10.1056/NEJMoa2313680
- Casey JD, et al. Bag-Mask Ventilation during Tracheal Intubation of Critically Ill Adults (PREVENT). N Engl J Med. 2019;380(9):811-821. doi:10.1056/NEJMoa1812405. https://doi.org/10.1056/NEJMoa1812405
- Russell DW, et al. Effect of Fluid Bolus Administration on Cardiovascular Collapse Among Critically Ill Patients Undergoing Tracheal Intubation (PREPARE II). JAMA. 2022;328(3):270-279. doi:10.1001/jama.2022.9792. https://doi.org/10.1001/jama.2022.9792
- Prescribing information, DailyMed (accessed 2026): (a) Quelicin (succinylcholine chloride) injection, Hospira; Boxed Warning, Contraindications, Dosage and Administration (label effective Aug 18, 2026). Quelicin. (b) Rocuronium bromide injection, Fresenius Kabi; Dosage and Administration (RSI); Clinical Pharmacology (duration) (label effective Aug 2, 2026). Rocuronium. (c) Bridion (sugammadex) injection, Merck Sharp & Dohme; Dosage and Administration (rocuronium reversal); Warnings (renal impairment) (label effective Mar 13, 2026). Bridion.
- Mushambi MC, Kinsella SM, Popat M, et al. Obstetric Anaesthetists' Association and Difficult Airway Society guidelines for the management of difficult and failed tracheal intubation in obstetrics. Anaesthesia. 2015;70(11):1286-1306. doi:10.1111/anae.13260. https://doi.org/10.1111/anae.13260
- Bisesi SA, Stauber SD, Hutchinson DJ, Acquisto NM. Current practices and safety of medication use during pediatric rapid sequence intubation. J Pediatr Pharmacol Ther. 2024;29(1):66-75. doi:10.5863/1551-6776-29.1.66. https://doi.org/10.5863/1551-6776-29.1.66
- Weiss SL, Peters MJ, Oczkowski SJW, et al. Surviving Sepsis Campaign international guidelines for the management of sepsis and septic shock in children 2026. Pediatr Crit Care Med. 2026;27(4):379-434. doi:10.1097/PCC.0000000000003927. https://doi.org/10.1097/PCC.0000000000003927
- Lewis K, Balas MC, Stollings JL, et al. A focused update to the clinical practice guidelines for the prevention and management of pain, anxiety, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2025;53(3):e711-e727. doi:10.1097/CCM.0000000000006574. https://doi.org/10.1097/CCM.0000000000006574
- American Heart Association. 2025 Guidelines for CPR and ECC, Part 8: Pediatric Advanced Life Support (PALS bradycardia algorithm, atropine dosing); Part 9: Adult Advanced Life Support (ACLS bradycardia algorithm); Part 10: Adult and Pediatric Special Circumstances of Resuscitation (hyperkalemia in cardiac arrest). Part 8; Part 9; Part 10.
Medical Disclaimer
- For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
- Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
- Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.